Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Concerta----1件: 203 💬
2D-methylphenidate
(Concerta, CONCERTA)		----1件: 84 💬
3Methylphenidate
(Concerta, CONCERTA)		1件: Methylphenidate2件: Methylphenidate hydrochloride (Concerta, CONCERTA),
Methylphenidate 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬5件: 6, 13, 34, 84, 113 💬
4Methylphenidate 10MG tablets
(Concerta, CONCERTA)		1件: Methylphenidate2件: Methylphenidate hydrochloride (Concerta, CONCERTA),
Methylphenidate 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 84 💬
5Methylphenidate hydrochloride
(Concerta, CONCERTA)		1件: Methylphenidate2件: Methylphenidate hydrochloride (Concerta, CONCERTA),
Methylphenidate 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬2件: 6, 13 💬
6Methylphenidate modified release
(Concerta, CONCERTA)		1件: Methylphenidate2件: Methylphenidate hydrochloride (Concerta, CONCERTA),
Methylphenidate 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
7Methylphenidate modified release 20 MG
(Concerta, CONCERTA)		1件: Methylphenidate2件: Methylphenidate hydrochloride (Concerta, CONCERTA),
Methylphenidate 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
8Methylphenidate modified release 30 MG
(Concerta, CONCERTA)		1件: Methylphenidate2件: Methylphenidate hydrochloride (Concerta, CONCERTA),
Methylphenidate 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
9Methylphenidate modified release 40 MG
(Concerta, CONCERTA)		1件: Methylphenidate2件: Methylphenidate hydrochloride (Concerta, CONCERTA),
Methylphenidate 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
10Methylphenidate oral solution
(Concerta, CONCERTA)		1件: Methylphenidate2件: Methylphenidate hydrochloride (Concerta, CONCERTA),
Methylphenidate 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 206 💬
11Methylphenidate, fluoxetin, risperidone
(Concerta, CONCERTA)		1件: Methylphenidate2件: Methylphenidate hydrochloride (Concerta, CONCERTA),
Methylphenidate 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬2件: 179, 206 💬